DXN Limited

DXN

DXN Ltd. engages in the construction of data center modules and sale to third-party data center owners. The Company’s core business is designing, engineering, manufacturing, maintaining and operating data centers. The Company’s divisions include Modular Division and Data Centre Operations. The Modular Division designs, engineers, manufactures, and deploys EDGE facilities and critical DC infrastructure. The Data Centre Operations division operates, maintains and markets data centers and critical infrastructure for its own DXN data centers, as well as its modular customers. Its solutions include DXN Modules/ Built to order, Edge Data Centers, Micro Edge, DXN-SYDO1 and others. Its Edge Data Centre solutions are designed and deployed to meet its customers individual needs at the Edge. Its DXN-SYD01 has been built to offer a complete and comprehensive colocation solution. Its range of services include engineering, project management, data center management and maintenance and support.

Dexus

DXS

Dexus engages in real estate investments, leasing and tenant services. The company is headquartered in Sydney, New South Wales and currently employs 647 full-time employees. The company went IPO on 2004-10-06. The Company’s segments include Office, Industrial, Co-investments, Property management, Funds Management, and Development and Trading. The Office segment consists of domestic office space with any associated retail space, as well as car parks and office developments owned directly or in joint ventures or partnerships. The Industrial segment includes domestic industrial properties, industrial estates and industrial developments. The Co-investments segment includes distribution income earned from investments in pooled property and real estate security funds. The Property management segment includes property management services for third party clients and owned assets. The Funds management segment consists of fund management of third-party client assets. The Development and trading segment includes revenue earned and costs incurred by the Company on development services for third party clients and inventory.

Dimerix Limited

DXB

Dimerix Ltd. engages in the investment of the research and development of biopharmaceutical drugs. The company is headquartered in Melbourne, Victoria. The firm is focused on developing new therapies in areas with unmet medical needs for global markets. The company is focused on developing its products, DMX-200, for Focal Segmental Glomerulosclerosis (FSGS), respiratory complications associated with COVID-19 and Diabetic Kidney Disease and is developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its DMX-200 and DMX-700 are identified using its assay, Receptor Heteromer Investigation Technology (Receptor-HIT), which is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets. The company has completed two Phase 2 studies: one in FSGS and one in diabetic kidney disease. Receptor-HIT is licensed to Excellerate Bioscience.

Dexus Convenience Retail Reit

DXC

Dexus Convenience Retail REIT engages in owning and management of portfolio of properties. The company is headquartered in Melbourne, Victoria and currently employs 0 full-time employees. The company went IPO on 2017-07-27. The portfolio is leased to tenants on long-term leases. The objective of the REIT is to provide investors with sustainable and stable income and the potential for both income and capital growth through annual rental increases. The REIT’s portfolio comprises approximately 112 service station sites predominantly located on the Eastern Seaboard states of Australia. The firm's fund manager (the Manager) is Convenience Retail Management Pty Limited, which is engaged in providing investment management services and property management services.